Larimar Therapeutics, Inc.LRMRNASDAQ
Loading
EBITDA Over TimeContracting
Percentile Rank0
Studio
Year-over-Year Change

Earnings before interest, taxes, depreciation, and amortization

Latest
$-170.36M
↓ 172% vs avg
Percentile
P0
Near historical low
Streak
3 yr
Consecutive declineContracting
Average
$-62.53M
Historical baseline
PeriodValueYoY Change
TTM$-170.36M-88.1%
2024$-90.57M-118.5%
2023$-41.45M-14.5%
2022$-36.21M+27.8%
2021$-50.14M-17.6%
2020$-42.65M-84.3%
2019$-23.14M+62.0%
2018$-60.81M-15.7%
2017$-52.58M+8.5%
2016$-57.44M-